Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis

Peritoneal Dialysis International

Volumn 29, Issue 4, 2009, Pages 443-449

  Sav, Tansu ^a   Oymak, Oktay ^a   Inanc, Mehmet Tugrul ^a   Dogan, Ali ^a   Tokgoz, Bulent ^a   Utas, Cengiz ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Hypertension; Icodextrin; Icodextrin metabolites; Left ventricular hypertrophy; Ultrafiltration failure

Indexed keywords

ICODEXTRIN; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERVOLEMIA; MALE; METABOLITE; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION;

EID: 70349495566     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900411     Document Type: Article

References (21)

1. Mehrotra R, Nolph KD. Current status of peritoneal dialysis. In: Gokal R, Khanna R, Krediet R, Nolph K, eds. Textbook of Peritoneal Dialysis. 2nd ed. Dordrecht: Kluwer Academic Publishers; 2000: 19-35.
2. Krediet RT, van Westrhenen R, Zweers MM, Struijk DG. Clinical advantages of new peritoneal dialysis solutions. Nephrol Dial Transplant 2002; 17(Suppl 3):16-18.
3. Yang X, Fang W, Bargman JM, Oreopoulos DG. High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis. Perit Dial Int 2008; 28:82-92.
4. Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, et al. Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002; 81: S23-33.
5. Martikainen TA, Teppo AM, Grönhagen-Riska C, Ekstrand AV. Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane? Perit Dial Int 2005; 25:453-60.
6. Gokal R. Peritoneal dialysis and complications of technique. In: Davison AM, Cameron JS, Grunfeld JP, Ponticelli C, Ritz E, Winerals CG, et al., eds. Oxford Textbook of Clinical Nephrology. 3rd ed. New York: Oxford University Press; 2005: 1954-87.
7. Mujais S. Ultrafiltration failure. In: Gokal R, Khanna R, Krediet R, Nolph K, eds. Textbook of Peritoneal Dialysis. 2nd ed. Dordrecht: Kluwer Academic Publishers; 2000: 499-513.
8. Mujais S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S5-21.
9. Korbet SM. Evaluation of ultrafiltration failure. Adv Ren Replace Ther 1998; 5:194-204.
10. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39:862-71.
11. Wolfson M, Piraino B, Hamburger RJ, Morton AR. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40:1055-65.
12. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16:546-54.
13. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
14. Wilkie ME, Plant MJ, Edwards L, Brown CB. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17:84-7.
15. Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2001; 2:2.
16. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-18.
17. Boudville NC, Cordy P, Millman K, Fairbairn L, Sharma A, Lindsay R, et al. Blood pressure, volume, and sodium control in an automated peritoneal dialysis population. Perit Dial Int 2007; 27:537-43.
18. Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63: 1556-63.
19. Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant 2000; 15:862-6.
20. Gunal AI, Ilkay E, Kirciman E, Karaca I, Dogukan A, Celiker H. Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodialysis patients: a cross-sectional study. Perit Dial Int 2003; 23:563-7.
21. Gobin J, Fernando S, Santacroce S, Finkelstein FO. The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients. Blood Purif 2008; 26:279-83. Epub 2008 Apr 18.